12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Deferiprone: Phase II ongoing

CorMedix said an independent DSMB recommended continuation of a double-blind, placebo-controlled, U.S. Phase II trial after an interim analysis of data from 30 patients showed that deferiprone was safe and...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >